Bio-Rad Laboratories Net Profit Margin 2010-2025 | BIO
Bio-Rad Laboratories Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2025-03-31 | $2.54B | $-2.16B | -85.20% |
2024-12-31 | $2.57B | $-1.84B | -71.86% |
2024-09-30 | $2.58B | $-0.78B | -30.16% |
2024-06-30 | $2.56B | $-1.33B | -51.72% |
2024-03-31 | $2.61B | $-0.32B | -12.36% |
2023-12-31 | $2.67B | $-0.64B | -23.85% |
2023-09-30 | $2.72B | $-0.16B | -5.85% |
2023-06-30 | $2.77B | $-0.43B | -15.46% |
2023-03-31 | $2.78B | $-0.19B | -6.87% |
2022-12-31 | $2.80B | $-3.63B | -129.44% |
2022-09-30 | $2.81B | $-6.02B | -214.62% |
2022-06-30 | $2.87B | $-1.93B | -67.19% |
2022-03-31 | $2.90B | $-0.09B | -3.11% |
2021-12-31 | $2.92B | $4.25B | 145.54% |
2021-09-30 | $2.98B | $6.67B | 223.69% |
2021-06-30 | $2.88B | $4.05B | 140.73% |
2021-03-31 | $2.70B | $4.11B | 151.98% |
2020-12-31 | $2.55B | $3.81B | 149.80% |
2020-09-30 | $2.38B | $3.52B | 147.90% |
2020-06-30 | $2.29B | $1.95B | 84.83% |
2020-03-31 | $2.33B | $1.58B | 67.77% |
2019-12-31 | $2.31B | $1.76B | 76.04% |
2019-09-30 | $2.31B | $0.38B | 16.31% |
2019-06-30 | $2.29B | $0.90B | 39.49% |
2019-03-31 | $2.29B | $0.57B | 25.00% |
2018-12-31 | $2.29B | $0.37B | 15.94% |
2018-09-30 | $2.29B | $1.28B | 55.67% |
2018-06-30 | $2.28B | $1.03B | 45.12% |
2018-03-31 | $2.21B | $0.77B | 34.67% |
2017-12-31 | $2.16B | $0.12B | 5.65% |
2017-09-30 | $2.11B | $0.02B | 0.76% |
2017-06-30 | $2.09B | $0.01B | 0.58% |
2017-03-31 | $2.10B | $0.03B | 1.19% |
2016-12-31 | $2.07B | $0.03B | 1.21% |
2016-09-30 | $2.07B | $0.09B | 4.55% |
2016-06-30 | $2.03B | $0.09B | 4.58% |
2016-03-31 | $2.02B | $0.10B | 5.10% |
2015-12-31 | $2.02B | $0.11B | 5.40% |
2015-09-30 | $2.05B | $0.10B | 4.98% |
2015-06-30 | $2.11B | $0.10B | 4.60% |
2015-03-31 | $2.14B | $0.10B | 4.72% |
2014-12-31 | $2.18B | $0.09B | 4.14% |
2014-09-30 | $2.18B | $0.08B | 3.72% |
2014-06-30 | $2.15B | $0.06B | 2.88% |
2014-03-31 | $2.14B | $0.07B | 3.03% |
2013-12-31 | $2.13B | $0.08B | 3.66% |
2013-09-30 | $2.10B | $0.09B | 4.33% |
2013-06-30 | $2.10B | $0.14B | 6.72% |
2013-03-31 | $2.08B | $0.15B | 7.39% |
2012-12-31 | $2.07B | $0.17B | 7.97% |
2012-09-30 | $2.05B | $0.18B | 8.90% |
2012-06-30 | $2.06B | $0.19B | 8.97% |
2012-03-31 | $2.08B | $0.18B | 8.53% |
2011-12-31 | $2.07B | $0.18B | 8.63% |
2011-09-30 | $2.06B | $0.19B | 9.09% |
2011-06-30 | $2.01B | $0.19B | 9.24% |
2011-03-31 | $1.96B | $0.18B | 9.39% |
2010-12-31 | $1.93B | $0.19B | 9.65% |
2010-09-30 | $1.89B | $0.16B | 8.26% |
2010-06-30 | $1.88B | $0.15B | 7.99% |
2010-03-31 | $1.84B | $0.15B | 8.17% |
2009-12-31 | $1.78B | $0.15B | 8.13% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $6.887B | $2.567B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $231.781B | 27.87 |
Boston Scientific (BSX) | United States | $152.324B | 38.13 |
Stryker (SYK) | United States | $149.641B | 31.29 |
EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
Medtronic (MDT) | Ireland | $114.146B | 16.18 |
Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
ResMed (RMD) | United States | $37.534B | 28.19 |
GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
Agilent Technologies (A) | United States | $34.457B | 22.46 |
Terumo (TRUMY) | Japan | $25.051B | 32.54 |
Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
Insulet (PODD) | United States | $20.934B | 82.17 |
Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
Baxter (BAX) | United States | $15.298B | 11.42 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
Haemonetics (HAE) | United States | $3.724B | 16.96 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.454B | 28.70 |
ICU Medical (ICUI) | United States | $3.341B | 24.63 |
QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
AtriCure (ATRC) | United States | $1.580B | 0.00 |
Acuren (TIC) | United States | $1.397B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
Neogen (NEOG) | United States | $1.194B | 15.28 |
BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
InMode (INMD) | Israel | $0.963B | 9.70 |
Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
Owens & Minor (OMI) | United States | $0.667B | 5.53 |
Evolus (EOLS) | United States | $0.623B | 0.00 |
CeriBell (CBLL) | United States | $0.596B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
Valneva SE (VALN) | France | $0.502B | 0.00 |
Surmodics (SRDX) | United States | $0.441B | 0.00 |
SNDL (SNDL) | Canada | $0.373B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
Quanterix (QTRX) | United States | $0.295B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
Cerus (CERS) | United States | $0.285B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
ZimVie (ZIMV) | United States | $0.264B | 12.01 |
Aurora Cannabis (ACB) | Canada | $0.257B | 76.17 |
Brainsway (BWAY) | Israel | $0.246B | 65.00 |
Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
Biote (BTMD) | United States | $0.225B | 6.34 |
Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
Omeros (OMER) | United States | $0.198B | 0.00 |
Organigram Global (OGI) | Canada | $0.193B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
Exagen (XGN) | United States | $0.145B | 0.00 |
FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.096B | 12.37 |
Jin Medical (ZJYL) | China | $0.093B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Apyx Medical (APYX) | United States | $0.086B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
Veru (VERU) | United States | $0.081B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Agape ATP (ATPC) | $0.071B | 0.00 | |
Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
ImmuCell (ICCC) | United States | $0.061B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
Nephros (NEPH) | United States | $0.040B | 53.29 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.82 |
Safety Shot (SHOT) | United States | $0.033B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Senestech (SNES) | United States | $0.011B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |